Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?

Published:2018-07 Issue:1 Volume:68 Page:389-389
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Polyzos Stergios A.¹^ORCID,Kountouras Jannis²,Anastasiadis Sotiris²,Doulberis Michael³,Katsinelos Panagiotis²

Affiliation:

1. First Department of Pharmacology, Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece

2. Second Medical Clinic, School of Medicine; Aristotle University of Thessaloniki; Thessaloniki Greece

3. Department of Internal Medicine; Bürgerspital Hospital; Solothurn Switzerland

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29897/fullpdf

Reference5 articles.

1. Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH);Younossi;Hepatology,2017

2. Nonalcoholic fatty liver disease: Multimodal treatment options for a pathogenetically multiple-hit disease;Polyzos;J Clin Gastroenterol,2012

3. Effect of atorvastatin, vitamin E and C on nonalcoholic fatty liver disease: is the combination required?;Arendt;Am J Gastroenterol,2011

4. Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial;Polyzos;Diabetes Obes Metab,2017

5. Emerging and future therapies for nonalcoholic steatohepatitis in adults;Mintziori;Expert Opin Pharmacother,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease;Annals of Gastroenterology;2024

2. A revisit of drugs and potential therapeutic targets against non-alcoholic fatty liver disease: learning from clinical trials;Journal of Endocrinological Investigation;2023-10-15

3. Combination therapies in nonalcoholic fatty liver disease using antidiabetic and disease-specific drugs;Annals of Gastroenterology;2023

4. Non-alcoholic Fatty Liver Disease in Children;Current Vascular Pharmacology;2023-01

5. Combination Therapies for Nonalcoholic Fatty Liver Disease;Journal of Personalized Medicine;2022-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3